<DOC>
	<DOC>NCT01224418</DOC>
	<brief_summary>This study is to evaluate efficacy of 6 months treatment of tacrolimus in active Rheumatoid Arthritis patients who showed unsuccessful response against methotrexate.</brief_summary>
	<brief_title>A Study to Evaluate the Efficacy of Tacrolimus in Rheumatoid Arthritis Patients Shown Unsuccessful Response to Methotrexate</brief_title>
	<detailed_description />
	<mesh_term>Arthritis</mesh_term>
	<mesh_term>Arthritis, Rheumatoid</mesh_term>
	<mesh_term>Methotrexate</mesh_term>
	<mesh_term>Tacrolimus</mesh_term>
	<criteria>Patients with more than 6 months history of rheumatoid arthritis according to ACR criteria Patients who have been treated unsuccessfully to more than single DMARDs including methotrexate at the discretion of investigator ESR ≥ 30 mm/h or CRP ≥ 1.0 mg/dL (ESR: Erythrocyte Sedimentation Rate, CRP: CReactive Protein) Patients are required to have at least 3 of 66 joints assessed as swollen Patients are required to have at least 6 of 68 joints assessed as painful with pressure Pregnant or breastfeeding patients. Patients who plan to bear children or breastfeed during the study and within 6 month after completion of study Previous experience of tacrolimus (ointment excluded) Renal impairment or serum creatinine &gt; 1.4 mg/dL Liver function failure as follows: viral hepatitis, nonviral hepatitis, cirrhosis, SGOT/SGPT &gt; 2x upper limit normal Patients with history of pancreatitis, glucose intolerance or complication or who indicates any of the following criteria:Blood glucose level &gt;110mg/dl before the meal and &gt;200mg/dl after the meal HbA1c &gt; 6.4% Cardiac disease(ischemic heart disease, treatmentrequiring arrhythmia, heart failure)or complications Other investigational drug within last 30 days Patients who have been treated with infliximab, adalimumab, or leflunomide within 8 weeks of start of the study</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>October 2010</verification_date>
	<keyword>Tacrolimus</keyword>
	<keyword>Prograf</keyword>
	<keyword>Calcinurin inhibitor</keyword>
	<keyword>Rheumatoid arthritis(RA)</keyword>
</DOC>